Efficacy of Denosumab for Control of Bone Mineral Density and Microarchitecture in Postmenopausal Women with Osteoporosis: A One-Year Experience (vol 27, pg 3977, 2013)

被引:0
|
作者
Petranova, T.
Sheytanov, I.
Monov, S.
Rashkov, R.
Kinov, P.
机构
关键词
D O I
10.1080/13102818.2014.978176
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
下载
收藏
页码:1190 / 1191
页数:2
相关论文
共 50 条
  • [41] Assessment of bone mineral density by DXA and the trabecular microarchitecture of the calcaneum by texture analysis in pre- and postmenopausal women in the evaluation of osteoporosis
    Karunanithi, R.
    Ganesan, S.
    Panicker, T. M. R.
    Korath, M. Paul
    Jagadeesan, K.
    JOURNAL OF MEDICAL PHYSICS, 2007, 32 (04) : 161 - 168
  • [42] BENEFICIAL EFFECTS OF ZOLEDRONATE COMPARED TO PLACEBO ON SPINE BONE MINERAL DENSITY (BMD) AND MICROARCHITECTURE (TBS) PARAMETERS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: A 3-YEAR STUDY
    Popp, Albrecht W.
    Buffat, Helene
    Lamy, Olivier
    Perrelet, Romain
    Hans, Didier
    Lippuner, Kurt
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S328 - S328
  • [43] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis (vol 30, pg 1187, 2019)
    Watts, N. B.
    Hattersley, G.
    Fitzpatrick, L. A.
    Wang, Y.
    Williams, G. C.
    Miller, P. D.
    Cosman, F.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (08) : 1603 - 1605
  • [44] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis (vol 30, pg 1187, 2019)
    Watts, N. B.
    Hattersley, G.
    Fitzpatrick, L. A.
    Wang, Y.
    Williams, G. C.
    Miller, P. D.
    Cosman, F.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (05) : 1017 - 1018
  • [45] One-year treatment of alendronate increases bone area, bone mineral density, bone mineral content in osteoporotic Japanese women.
    Takata, S
    Yasui, N
    Takahashi, M
    Abbaspour, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S394 - S394
  • [46] Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene (vol 10, pg 330, 1999)
    Meunier, PJ
    Vignot, E
    Garnero, P
    Confavreux, E
    Paris, E
    Liu-Leage, S
    Sarkar, S
    Liu, T
    Wong, M
    Draper, MW
    OSTEOPOROSIS INTERNATIONAL, 1999, 10 (05) : 433 - 433
  • [47] Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study
    C. Senn
    B. Günther
    A. W. Popp
    R. Perrelet
    D. Hans
    K. Lippuner
    Osteoporosis International, 2014, 25 : 1945 - 1951
  • [48] INCREASED BONE MINERAL DENSITY (BMD) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS (OP) RECEIVING TWO DENOSUMAB INJECTIONS IN ROUTINE CLINICAL PRACTICE IN BULGARIA
    Boyanov, M.
    Shinkov, A.
    Psachoulia, E.
    Intorcia, M.
    Petkova, R.
    VALUE IN HEALTH, 2014, 17 (07) : A389 - A389
  • [49] Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study
    Senn, C.
    Guenther, B.
    Popp, A. W.
    Perrelet, R.
    Hans, D.
    Lippuner, K.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (07) : 1945 - 1951
  • [50] COMPARISON OF THE EFFECT OF TRANSITIONING FROM TERIPARATIDE TO DENOSUMAB OR BISPHOSPHONATES ON BONE MINERAL DENSITY OF LUMBAR SPINE AND FEMORAL NECK IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Mole, E.
    Mole, I.
    Theodorakopoulos, S.
    Moschou, D.
    Zoupidou, K.
    Gazi, S.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S460 - S460